267 related articles for article (PubMed ID: 27926918)
1. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
[TBL] [Abstract][Full Text] [Related]
2. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
Evans DS; Alphonsus K; Umaru J; Eigege A; Miri E; Mafuyai H; Gonzales-Peralta C; Adamani W; Pede E; Umbugadu C; Saka Y; Okoeguale B; Richards FO
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3113. PubMed ID: 25233351
[TBL] [Abstract][Full Text] [Related]
3. Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria.
Anagbogu IN; Saka YA; Surakat OA; Okoronkwo C; Davies E; Oyale P; Ekpo UF; Amazigo UV; Barbre K; Igbe M; Nyior A; Jacob SM; Gideon Nteun U; Abubakar Umar Z
Parasit Vectors; 2022 Jun; 15(1):201. PubMed ID: 35698164
[TBL] [Abstract][Full Text] [Related]
4. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
[TBL] [Abstract][Full Text] [Related]
5. Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali.
Dolo H; Coulibaly YI; Sow M; Dembélé M; Doumbia SS; Coulibaly SY; Sangare MB; Dicko I; Diallo AA; Soumaoro L; Coulibaly ME; Diarra D; Colebunders R; Nutman TB; Walker M; Basáñez MG
Clin Infect Dis; 2021 May; 72(9):1585-1593. PubMed ID: 32206773
[TBL] [Abstract][Full Text] [Related]
6. Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test.
Dolo H; Coulibaly YI; Dembele B; Guindo B; Coulibaly SY; Dicko I; Doumbia SS; Dembele M; Traore MO; Goita S; Dolo M; Soumaoro L; Coulibaly ME; Diallo AA; Diarra D; Zhang Y; Colebunders R; Nutman TB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007064. PubMed ID: 30699120
[TBL] [Abstract][Full Text] [Related]
7. Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
Endeshaw T; Taye A; Tadesse Z; Katabarwa MN; Shafi O; Seid T; Richards FO
Pathog Glob Health; 2015; 109(7):344-51. PubMed ID: 26878935
[TBL] [Abstract][Full Text] [Related]
8. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
9. Integrated Prevalence Assessment of Wuchereria bancrofti and Onchocerca volvulus in Three Co-Endemic Districts of Gambella Region, Ethiopia.
Hassen M; Mohammed A; Endeshaw T; Seid T; Samuel F; Asmare T; Birhanu H; Bekele F; Yayeh A; Seife F; Tamiru M; Meribo K; Tadesse Z; Griswold E; Katabarwa M; Richards F; Noland GS
Am J Trop Med Hyg; 2023 Oct; 109(4):844-849. PubMed ID: 37696513
[TBL] [Abstract][Full Text] [Related]
10. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
[TBL] [Abstract][Full Text] [Related]
11. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
[TBL] [Abstract][Full Text] [Related]
12. The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.
Richards FO; Eigege A; Umaru J; Kahansim B; Adelamo S; Kadimbo J; Danboyi J; Mafuyai H; Saka Y; Noland GS; Anyaike C; Igbe M; Rakers L; Griswold E; Unnasch TR; Nwoke BEB; Miri E
Am J Trop Med Hyg; 2020 Mar; 102(3):582-592. PubMed ID: 32043442
[TBL] [Abstract][Full Text] [Related]
13. Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones.
Dolo H; Coulibaly ME; Sow M; Coulibaly YI; Doumbia M; Sangare M; Sanogo A; Dembele B; Guindo B; Coulibaly M; Keita M; Soumaoro L; Diarra D; Dicko B; Hamill L; Doumbia S; Sangho H; Sangare Y; Zhang Y; Tallant J; Yaro AS; Mackenzie C; Nutman TB; Boakye D
PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011632. PubMed ID: 37967137
[TBL] [Abstract][Full Text] [Related]
14. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
[TBL] [Abstract][Full Text] [Related]
15. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
17. Interruption of onchocerciasis transmission in Bioko Island: Accelerating the movement from control to elimination in Equatorial Guinea.
Herrador Z; Garcia B; Ncogo P; Perteguer MJ; Rubio JM; Rivas E; Cimas M; Ordoñez G; de Pablos S; Hernández-González A; Nguema R; Moya L; Romay-Barja M; Garate T; Barbre K; Benito A
PLoS Negl Trop Dis; 2018 May; 12(5):e0006471. PubMed ID: 29723238
[TBL] [Abstract][Full Text] [Related]
18. Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone.
Kargbo-Labour I; Bah MS; Melchers NVSV; Conteh A; Redwood-Sawyerr V; Stolk WA; Paye J; Sonnie M; Veinoglou A; Koroma JB; Hodges MH; Weaver AM; Zhang Y
Parasit Vectors; 2024 Mar; 17(1):121. PubMed ID: 38468307
[TBL] [Abstract][Full Text] [Related]
19. Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
Martin D; Wiegand R; Goodhew B; Lammie P; Mkocha H; Kasubi M
Am J Trop Med Hyg; 2018 Oct; 99(4):937-939. PubMed ID: 30062986
[TBL] [Abstract][Full Text] [Related]
20. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
